Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) where fluorinated aromatic moieties enhance metabolic stability and bioavailability. Its structure supports asymmetric synthesis routes, making it valuable in producing enantiomerically pure drugs. Commonly applied in research and development for central nervous system agents and anti-inflammatory compounds. Also utilized in the preparation of radiolabeled derivatives for metabolic studies due to the presence of fluorine atoms.